Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,244 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,244 Papers indexed
1,440 Papers AI scored
40,244 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-08 10:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40244 results
D
Total Body PET.
PMID 42149178 Published: 2026-01-01 Ingested: 2026-08-02 12:06 AM Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Supporting Survivor-Centered Care Through Digital Health Integration.
PMID 42145039 Published: 2026-05-18 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
How I Approach Anxiety in Children and Teens With Cancer.
PMID 42145027 Published: 2026-05-18 Ingested: 2026-08-02 12:06 AM Pediatric blood & cancer
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Cerebellar Tuberculoma as a Rare Manifestation of Central Nervous System Tuberculosis: Literature Review and Clinical Case.
PMID 42122029 Published: 2026-04-28 Ingested: 2026-08-02 12:06 AM Diagnostics (Basel, Switzerland)
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Polycystic bone disease: A new family.
PMID 42119630 Published: 2026-05-10 Ingested: 2026-08-02 12:06 AM Bone
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
False Positive Uptake of 123I-MIBG in Celiac Ganglion in a Patient With Neuroblastoma.
PMID 42113568 Published: 2026-04-29 Ingested: 2026-08-02 12:06 AM Clinical nuclear medicine
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Recurrent Infraorbital Rim Osteoma in a Pediatric Patient: A Brief Report.
PMID 42113032 Published: 2026-05-11 Ingested: 2026-08-02 12:07 AM The Journal of craniofacial surgery
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Duodeno-jejunal intussusception: an unusual manifestation of ampullary adenocarcinoma.
PMID 42111148 Published: 2026-05-07 Ingested: 2026-08-02 12:07 AM Journal of surgical case reports
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Left Behind: Addressing the Impact of Family Separation Due to Immigration Policies on the Suffering of Patients with Advanced Cancer.
PMID 42095281 Published: 2026-05-07 Ingested: 2026-08-02 12:07 AM Journal of palliative medicine
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

D
Age distinguishes selection from causation in cancer genomes.
PMID 42086853 Published: 2026-05-05 Ingested: 2026-08-02 12:06 AM Nature genetics
AI -
Standard 54.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 54.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

Previous
Page 2709 of 3354
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic